ID   RGRF2_HUMAN             Reviewed;        1237 AA.
AC   O14827; B9EG89; Q9UK56;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   04-DEC-2007, sequence version 2.
DT   07-APR-2021, entry version 173.
DE   RecName: Full=Ras-specific guanine nucleotide-releasing factor 2;
DE            Short=Ras-GRF2;
DE   AltName: Full=Ras guanine nucleotide exchange factor 2;
GN   Name=RASGRF2; Synonyms=GRF2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], OLIGOMERIZATION, INTERACTION WITH RASGRF1, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Hippocampus;
RX   PubMed=10373510; DOI=10.1128/mcb.19.7.4611;
RA   Anborgh P.H., Qian X., Papageorge A.G., Vass W.C., DeClue J.E., Lowy D.R.;
RT   "Ras-specific exchange factor GRF: oligomerization through its Dbl homology
RT   domain and calcium-dependent activation of Raf.";
RL   Mol. Cell. Biol. 19:4611-4622(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], INTERACTION WITH EPB49, SUBCELLULAR LOCATION,
RP   AND TISSUE SPECIFICITY.
RC   TISSUE=Fetal brain;
RX   PubMed=11856323; DOI=10.1046/j.0014-2956.2001.02694.x;
RA   Lutchman M., Kim A.C., Cheng L., Whitehead I.P., Oh S.S., Hanspal M.,
RA   Boukharov A.A., Hanada T., Chishti A.H.;
RT   "Dematin interacts with the Ras-guanine nucleotide exchange factor Ras-GRF2
RT   and modulates mitogen-activated protein kinase pathways.";
RL   Eur. J. Biochem. 269:638-649(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12176907; DOI=10.1182/blood-2001-12-0193;
RA   Rabiet M.-J., Tardif M., Braun L., Boulay F.;
RT   "Inhibitory effects of a dominant-interfering form of the Rho-GTPase Cdc42
RT   in the chemoattractant-elicited signaling pathways leading to NADPH oxidase
RT   activation in differentiated HL-60 cells.";
RL   Blood 100:1835-1844(2002).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH CDK5R1, PHOSPHORYLATION AT
RP   SER-737 BY CDK5, AND MUTAGENESIS OF SER-737.
RX   PubMed=15128856; DOI=10.1523/jneurosci.0690-04.2004;
RA   Kesavapany S., Amin N., Zheng Y.-L., Nijhara R., Jaffe H., Sihag R.,
RA   Gutkind J.S., Takahashi S., Kulkarni A., Grant P., Pant H.C.;
RT   "p35/cyclin-dependent kinase 5 phosphorylation of ras guanine nucleotide
RT   releasing factor 2 (RasGRF2) mediates Rac-dependent extracellular signal-
RT   regulated kinase 1/2 activity, altering RasGRF2 and microtubule-associated
RT   protein 1b distribution in neurons.";
RL   J. Neurosci. 24:4421-4431(2004).
RN   [7]
RP   SUBCELLULAR LOCATION.
RX   PubMed=14749369; DOI=10.1128/mcb.24.4.1516-1530.2004;
RA   Arozarena I., Matallanas D., Berciano M.T., Sanz-Moreno V., Calvo F.,
RA   Munoz M.T., Egea G., Lafarga M., Crespo P.;
RT   "Activation of H-Ras in the endoplasmic reticulum by the RasGRF family
RT   guanine nucleotide exchange factors.";
RL   Mol. Cell. Biol. 24:1516-1530(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-746, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [9]
RP   VARIANTS [LARGE SCALE ANALYSIS] HIS-114; ASN-538 AND GLU-1216.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Functions as a calcium-regulated nucleotide exchange factor
CC       activating both Ras and RAC1 through the exchange of bound GDP for GTP.
CC       Preferentially activates HRAS in vivo compared to RRAS based on their
CC       different types of prenylation. Functions in synaptic plasticity by
CC       contributing to the induction of long term potentiation.
CC       {ECO:0000269|PubMed:15128856}.
CC   -!- SUBUNIT: Homooligomer and heterooligomer with RASGRF1. Interacts with
CC       Ras and RAC1. Interacts in a calcium-dependent manner with calmodulin
CC       (By similarity). Interacts with CDK5R1 and EPB49. Interacts with the
CC       AMPA receptor through GRIA1 (By similarity). Interacts with
CC       microtubules (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cell membrane; Peripheral membrane
CC       protein. Endoplasmic reticulum membrane; Peripheral membrane protein.
CC       Note=Translocates to membranes when activated. Found both at cell
CC       periphery and along the axon of neurons (By similarity). {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Widely expressed with higher expression in brain,
CC       followed by heart, lung, pancreas and kidney. Detected in placenta.
CC       Expressed in brain and lung (at protein level).
CC       {ECO:0000269|PubMed:10373510, ECO:0000269|PubMed:11856323}.
CC   -!- DOMAIN: The Ras-GEF domain and the N-terminal Ras-GEF domain form a
CC       Ras-binding site and mediate Ras activation. {ECO:0000250}.
CC   -!- DOMAIN: The IQ domain mediates the calcium-dependent interaction with
CC       calmodulin but is dispensable for the Ras-GEF activity. {ECO:0000250}.
CC   -!- DOMAIN: The DH (DBL-homology) domain mediates interaction with RASGRF1
CC       and EPB49 and is required for RAC1 activation.
CC   -!- PTM: Phosphorylated by CDK5; down-regulates RASGRF2-mediated RAC1
CC       activation. {ECO:0000269|PubMed:15128856}.
CC   -!- PTM: Ubiquitinated upon interaction with Ras. Ubiquitination leads to
CC       degradation through the 26S proteasome (By similarity). {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF023130; AAB80953.1; -; mRNA.
DR   EMBL; AF181250; AAD55268.1; -; mRNA.
DR   EMBL; CH471084; EAW95863.1; -; mRNA.
DR   EMBL; BC126112; AAI26113.1; -; mRNA.
DR   EMBL; BC136296; AAI36297.1; -; mRNA.
DR   CCDS; CCDS4052.1; -.
DR   RefSeq; NP_008840.1; NM_006909.2.
DR   SMR; O14827; -.
DR   BioGRID; 111859; 23.
DR   IntAct; O14827; 12.
DR   STRING; 9606.ENSP00000265080; -.
DR   iPTMnet; O14827; -.
DR   PhosphoSitePlus; O14827; -.
DR   BioMuta; RASGRF2; -.
DR   EPD; O14827; -.
DR   jPOST; O14827; -.
DR   MassIVE; O14827; -.
DR   PaxDb; O14827; -.
DR   PeptideAtlas; O14827; -.
DR   PRIDE; O14827; -.
DR   ProteomicsDB; 48258; -.
DR   Antibodypedia; 12760; 30 antibodies.
DR   Ensembl; ENST00000265080; ENSP00000265080; ENSG00000113319.
DR   GeneID; 5924; -.
DR   KEGG; hsa:5924; -.
DR   UCSC; uc003kha.3; human.
DR   CTD; 5924; -.
DR   DisGeNET; 5924; -.
DR   GeneCards; RASGRF2; -.
DR   HGNC; HGNC:9876; RASGRF2.
DR   HPA; ENSG00000113319; Tissue enhanced (brain, ovary).
DR   MIM; 606614; gene.
DR   neXtProt; NX_O14827; -.
DR   OpenTargets; ENSG00000113319; -.
DR   PharmGKB; PA34239; -.
DR   VEuPathDB; HostDB:ENSG00000113319.11; -.
DR   eggNOG; KOG3417; Eukaryota.
DR   GeneTree; ENSGT00940000155679; -.
DR   HOGENOM; CLU_003405_0_1_1; -.
DR   InParanoid; O14827; -.
DR   OMA; DGCHLTI; -.
DR   OrthoDB; 70788at2759; -.
DR   PhylomeDB; O14827; -.
DR   TreeFam; TF317296; -.
DR   PathwayCommons; O14827; -.
DR   Reactome; R-HSA-193648; NRAGE signals death through JNK.
DR   Reactome; R-HSA-194840; Rho GTPase cycle.
DR   Reactome; R-HSA-416482; G alpha (12/13) signalling events.
DR   Reactome; R-HSA-442982; Ras activation upon Ca2+ influx through NMDA receptor.
DR   Reactome; R-HSA-5673001; RAF/MAP kinase cascade.
DR   SIGNOR; O14827; -.
DR   BioGRID-ORCS; 5924; 3 hits in 982 CRISPR screens.
DR   ChiTaRS; RASGRF2; human.
DR   GeneWiki; RASGRF2; -.
DR   GenomeRNAi; 5924; -.
DR   Pharos; O14827; Tbio.
DR   PRO; PR:O14827; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; O14827; protein.
DR   Bgee; ENSG00000113319; Expressed in middle temporal gyrus and 166 other tissues.
DR   ExpressionAtlas; O14827; baseline and differential.
DR   Genevisible; O14827; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; IMP:BHF-UCL.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0060291; P:long-term synaptic potentiation; IEA:Ensembl.
DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome.
DR   GO; GO:2000310; P:regulation of NMDA receptor activity; IEA:Ensembl.
DR   GO; GO:0035023; P:regulation of Rho protein signal transduction; IEA:InterPro.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome.
DR   GO; GO:0034976; P:response to endoplasmic reticulum stress; IMP:BHF-UCL.
DR   GO; GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro.
DR   CDD; cd00155; RasGEF; 1.
DR   CDD; cd00160; RhoGEF; 1.
DR   Gene3D; 1.10.840.10; -; 1.
DR   Gene3D; 1.20.900.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 2.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR008937; Ras-like_GEF.
DR   InterPro; IPR000651; Ras-like_Gua-exchang_fac_N.
DR   InterPro; IPR019804; Ras_G-nucl-exch_fac_CS.
DR   InterPro; IPR023578; Ras_GEF_dom_sf.
DR   InterPro; IPR001895; RASGEF_cat_dom.
DR   InterPro; IPR036964; RASGEF_cat_dom_sf.
DR   InterPro; IPR030744; RasGRF2.
DR   PANTHER; PTHR23113; PTHR23113; 1.
DR   PANTHER; PTHR23113:SF187; PTHR23113:SF187; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00617; RasGEF; 1.
DR   Pfam; PF00618; RasGEF_N; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   SMART; SM00233; PH; 2.
DR   SMART; SM00147; RasGEF; 1.
DR   SMART; SM00229; RasGEFN; 2.
DR   SMART; SM00325; RhoGEF; 1.
DR   SUPFAM; SSF48065; SSF48065; 1.
DR   SUPFAM; SSF48366; SSF48366; 1.
DR   PROSITE; PS50010; DH_2; 1.
DR   PROSITE; PS50096; IQ; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 2.
DR   PROSITE; PS00720; RASGEF; 1.
DR   PROSITE; PS50009; RASGEF_CAT; 1.
DR   PROSITE; PS50212; RASGEF_NTER; 1.
PE   1: Evidence at protein level;
KW   Calcium; Calmodulin-binding; Cell membrane; Coiled coil; Cytoplasm;
KW   Endoplasmic reticulum; Guanine-nucleotide releasing factor; Membrane;
KW   Phosphoprotein; Reference proteome; Repeat; Ubl conjugation.
FT   CHAIN           1..1237
FT                   /note="Ras-specific guanine nucleotide-releasing factor 2"
FT                   /id="PRO_0000312863"
FT   DOMAIN          22..133
FT                   /note="PH 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          205..234
FT                   /note="IQ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   DOMAIN          243..429
FT                   /note="DH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00062"
FT   DOMAIN          470..588
FT                   /note="PH 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          635..756
FT                   /note="N-terminal Ras-GEF"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00135"
FT   DOMAIN          1002..1234
FT                   /note="Ras-GEF"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00168"
FT   REGION          744..752
FT                   /note="Regulates proteasomal degradation"
FT                   /evidence="ECO:0000250"
FT   REGION          1099..1128
FT                   /note="Responsible of the affinity for farnesylated versus
FT                   geranylgeranylated Ras"
FT                   /evidence="ECO:0000250"
FT   COILED          155..193
FT                   /evidence="ECO:0000255"
FT   MOD_RES         726
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P70392"
FT   MOD_RES         727
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P70392"
FT   MOD_RES         737
FT                   /note="Phosphoserine; by CDK5"
FT                   /evidence="ECO:0000269|PubMed:15128856"
FT   MOD_RES         746
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   MOD_RES         848
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P70392"
FT   MOD_RES         852
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P70392"
FT   MOD_RES         972
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P70392"
FT   VARIANT         114
FT                   /note="R -> H (in a colorectal cancer sample; somatic
FT                   mutation; dbSNP:rs779986744)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_037595"
FT   VARIANT         538
FT                   /note="D -> N (in a breast cancer sample; somatic mutation;
FT                   dbSNP:rs1466151520)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_037596"
FT   VARIANT         713
FT                   /note="L -> W (in dbSNP:rs16878472)"
FT                   /id="VAR_037597"
FT   VARIANT         1216
FT                   /note="D -> E (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_037598"
FT   MUTAGEN         737
FT                   /note="S->A: Loss of phosphorylation by CDK5."
FT                   /evidence="ECO:0000269|PubMed:15128856"
FT   CONFLICT        561
FT                   /note="A -> R (in Ref. 1; AAB80953)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1237 AA;  140764 MW;  A136CF4FA111FDD9 CRC64;
     MQKSVRYNEG HALYLAFLAR KEGTKRGFLS KKTAEASRWH EKWFALYQNV LFYFEGEQSC
     RPAGMYLLEG CSCERTPAPP RAGAGQGGVR DALDKQYYFT VLFGHEGQKP LELRCEEEQD
     GKEWMEAIHQ ASYADILIER EVLMQKYIHL VQIVETEKIA ANQLRHQLED QDTEIERLKS
     EIIALNKTKE RMRPYQSNQE DEDPDIKKIK KVQSFMRGWL CRRKWKTIVQ DYICSPHAES
     MRKRNQIVFT MVEAESEYVH QLYILVNGFL RPLRMAASSK KPPISHDDVS SIFLNSETIM
     FLHEIFHQGL KARIANWPTL ILADLFDILL PMLNIYQEFV RNHQYSLQVL ANCKQNRDFD
     KLLKQYEANP ACEGRMLETF LTYPMFQIPR YIITLHELLA HTPHEHVERK SLEFAKSKLE
     ELSRVMHDEV SDTENIRKNL AIERMIVEGC DILLDTSQTF IRQGSLIQVP SVERGKLSKV
     RLGSLSLKKE GERQCFLFTK HFLICTRSSG GKLHLLKTGG VLSLIDCTLI EEPDASDDDS
     KGSGQVFGHL DFKIVVEPPD AAAFTVVLLA PSRQEKAAWM SDISQCVDNI RCNGLMTIVF
     EENSKVTVPH MIKSDARLHK DDTDICFSKT LNSCKVPQIR YASVERLLER LTDLRFLSID
     FLNTFLHTYR IFTTAAVVLG KLSDIYKRPF TSIPVRSLEL FFATSQNNRG EHLVDGKSPR
     LCRKFSSPPP LAVSRTSSPV RARKLSLTSP LNSKIGALDL TTSSSPTTTT QSPAASPPPH
     TGQIPLDLSR GLSSPEQSPG TVEENVDNPR VDLCNKLKRS IQKAVLESAP ADRAGVESSP
     AADTTELSPC RSPSTPRHLR YRQPGGQTAD NAHCSVSPAS AFAIATAAAG HGSPPGFNNT
     ERTCDKEFII RRTATNRVLN VLRHWVSKHA QDFELNNELK MNVLNLLEEV LRDPDLLPQE
     RKAAANILRA LSQDDQDDIH LKLEDIIQMT DCMKAECFES LSAMELAEQI TLLDHVIFRS
     IPYEEFLGQG WMKLDKNERT PYIMKTSQHF NDMSNLVASQ IMNYADVSSR ANAIEKWVAV
     ADICRCLHNY NGVLEITSAL NRSAIYRLKK TWAKVSKQTK ALMDKLQKTV SSEGRFKNLR
     ETLKNCNPPA VPYLGMYLTD LAFIEEGTPN FTEEGLVNFS KMRMISHIIR EIRQFQQTSY
     RIDHQPKVAQ YLLDKDLIID EDTLYELSLK IEPRLPA
//
